BR0015980A - Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii - Google Patents
Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina iiInfo
- Publication number
- BR0015980A BR0015980A BR0015980-8A BR0015980A BR0015980A BR 0015980 A BR0015980 A BR 0015980A BR 0015980 A BR0015980 A BR 0015980A BR 0015980 A BR0015980 A BR 0015980A
- Authority
- BR
- Brazil
- Prior art keywords
- glaucoma
- prophylaxis
- agent
- treatment
- angiotensin
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 4
- 239000003795 chemical substances by application Substances 0.000 title abstract 4
- 238000011321 prophylaxis Methods 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 4
- 229940123413 Angiotensin II antagonist Drugs 0.000 title abstract 3
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 abstract 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
"AGENTE PARA PROFILAXIA OU TRATAMENTO DO GLAUCOMA, E, USO DE UM ANTAGONISTA DE ANGIOTENSINA II". Esta invenção refere-se a um agente para a profilaxia ou o tratamento do glaucoma. Um agente para a profilaxia ou o tratamento do glaucoma que compreende um antagonista de angiotensina II e pelo menos um composto selecionado de bloqueadores de receptor de adrenalina, prostaglandinas e inibidores de anidrase carbónica como ingredientes ativos para uso simultâneo, separado ou sucessivo dos citados ingredientes ativos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34152499 | 1999-12-01 | ||
JP2000078769 | 2000-03-21 | ||
PCT/JP2000/008545 WO2001039805A1 (fr) | 1999-12-01 | 2000-12-01 | Coprescription pour le traitement du glaucome |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0015980A true BR0015980A (pt) | 2002-11-12 |
Family
ID=26576988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0015980-8A BR0015980A (pt) | 1999-12-01 | 2000-12-01 | Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii |
Country Status (22)
Country | Link |
---|---|
US (4) | US7307096B2 (pt) |
EP (3) | EP1344535A3 (pt) |
JP (1) | JP4000505B2 (pt) |
KR (3) | KR20040045029A (pt) |
CN (3) | CN1615879A (pt) |
AT (1) | ATE332145T1 (pt) |
AU (1) | AU773110B2 (pt) |
BR (1) | BR0015980A (pt) |
CA (1) | CA2392804C (pt) |
CZ (1) | CZ20021829A3 (pt) |
DE (1) | DE60029242T2 (pt) |
ES (1) | ES2267586T3 (pt) |
HK (1) | HK1047239B (pt) |
HU (1) | HUP0204049A3 (pt) |
IL (2) | IL149444A0 (pt) |
MX (1) | MXPA02005505A (pt) |
NO (1) | NO20022584L (pt) |
NZ (1) | NZ518930A (pt) |
PL (1) | PL201783B1 (pt) |
RU (4) | RU2002114335A (pt) |
TW (1) | TWI290470B (pt) |
WO (1) | WO2001039805A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002085372A1 (fr) * | 2001-04-19 | 2002-10-31 | Teika Pharmaceutical Co., Ltd. | Medicaments et trousses medicales |
TW200305424A (en) * | 2002-01-29 | 2003-11-01 | Santen Pharmaceutical Co Ltd | Glaucoma-treating agent comprising bunazosin and prostaglandin |
US20050119299A1 (en) * | 2002-03-08 | 2005-06-02 | Sankyo Company, Limited | Ophthalmic solutions containing tetrazole derivatives |
US8580851B2 (en) | 2002-08-21 | 2013-11-12 | Sucampo Ag | Ophthalmic solution |
US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
ES2431640T3 (es) * | 2003-08-21 | 2013-11-27 | Sucampo Ag | Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad |
JP2005263792A (ja) * | 2004-02-19 | 2005-09-29 | Santen Pharmaceut Co Ltd | 澄明なラタノプロスト点眼液 |
WO2005079809A1 (ja) * | 2004-02-19 | 2005-09-01 | Santen Pharmaceutical Co., Ltd. | 澄明なラタノプロスト点眼液 |
EP1994933B1 (en) * | 2006-03-13 | 2017-04-26 | R-Tech Ueno, Ltd. | Aqueous composition |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
CN102970973A (zh) * | 2010-05-07 | 2013-03-13 | 太阳医药高级研发有限公司 | 新型眼用组合物 |
RU2443416C2 (ru) * | 2010-05-17 | 2012-02-27 | Республиканское Унитарное производственное предприятие "Белмедпрепараты" | Капли глазные |
CA2860453C (en) | 2011-01-24 | 2020-04-28 | Inceptum Research & Therapeutics, Inc. | Compositions comprising a prostaglandin for treating neuropsychiatric conditions |
KR101327267B1 (ko) | 2012-04-26 | 2013-11-11 | 한양대학교 에리카산학협력단 | 엔드이펙터용 구동력 전달장치 |
JP6686023B2 (ja) | 2014-11-25 | 2020-04-22 | エキシモア・リミテッドEximore Ltd. | 生物活性剤または生物活性剤類を送達する組成物および方法 |
SG11201704740WA (en) * | 2014-12-12 | 2017-07-28 | Kowa Co | Aqueous composition |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3619370A (en) | 1969-04-21 | 1971-11-09 | Frosst & Co Charles E | Microbial reduction of thiadiazoles |
JPS536156B2 (pt) | 1972-10-30 | 1978-03-04 | ||
IE50901B1 (en) * | 1980-03-04 | 1986-08-06 | Merck & Co Inc | Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure |
US4394382A (en) | 1980-06-17 | 1983-07-19 | Kowa Company, Ltd. | Dihydrobenzopyran compounds and pharmaceutical composition comprising said compounds |
DE3568431D1 (en) * | 1984-12-12 | 1989-04-06 | Merck & Co Inc | Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them |
US4863922A (en) | 1984-12-12 | 1989-09-05 | Merck & Co., Inc. | Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
US5182264A (en) * | 1986-03-07 | 1993-01-26 | Schering Corporation | Angiotensin II receptor blockers as antiglaucoma agents |
JP2610619B2 (ja) * | 1987-07-22 | 1997-05-14 | エーザイ株式会社 | 高眼圧症治療用点眼剤 |
JPS6426518U (pt) | 1987-08-11 | 1989-02-15 | ||
DE03014533T1 (de) | 1988-09-06 | 2004-07-15 | Pharmacia Ab | Prostaglandinderivative zur Behandlung von Glaukom oder okuläre Hypertension |
ATE186456T1 (de) | 1988-09-09 | 1999-11-15 | Draenert Klaus | Hüftgelenksprothese |
EP0375299A1 (en) * | 1988-12-19 | 1990-06-27 | Merck & Co. Inc. | Combinations of angiotensin converting enzyme, and carbonic anhydrase, inhibitors for treating glaucoma |
US5273976A (en) * | 1989-04-06 | 1993-12-28 | Sankyo Company, Limited | Ocular hypotensive agents |
US5175161A (en) * | 1989-04-06 | 1992-12-29 | Sankyo Company, Limited | Occular hypotensive agents |
WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
CA2057089A1 (en) * | 1990-12-07 | 1992-06-08 | Eric E. Allen | Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists |
US5250521A (en) * | 1990-12-07 | 1993-10-05 | Merck & Co., Inc. | Substituted pyrazolopyrimidines as angiotensin II antagonists |
NZ242724A (en) * | 1991-05-15 | 1994-09-27 | Du Pont | Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker |
IL104648A0 (en) | 1992-02-13 | 1993-06-10 | Merck & Co Inc | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a prostaglandin or prostaglandin derivative |
WO1993016701A2 (en) * | 1992-02-21 | 1993-09-02 | Alcon Laboratories, Inc. | Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
ES2243933T3 (es) * | 1994-02-08 | 2005-12-01 | Novartis Ag | Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii. |
CA2185524C (en) * | 1994-03-16 | 2006-12-05 | Tomihisa Yokoyama | Ocular tension depressant |
HUT74734A (en) * | 1994-03-16 | 1997-02-28 | Sankyo Co | Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity |
US5760249A (en) * | 1995-08-29 | 1998-06-02 | Merck & Co., Inc. | Synthesis of hydroxysulfone and related compounds |
US5741810A (en) | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
DE69713890T3 (de) * | 1996-04-05 | 2006-09-07 | Takeda Pharmaceutical Co. Ltd. | Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin-sensitivität erhöht |
AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
AU725677B2 (en) | 1997-05-09 | 2000-10-19 | Mount Sinai School Of Medicine Of The City University Of New York, The | 8-iso-prostaglandins for glaucoma therapy |
HUP0201466A3 (en) * | 1999-06-11 | 2003-04-28 | Sankyo Co | Ocular tension lowering composition for topical administration |
-
2000
- 2000-11-30 TW TW089125460A patent/TWI290470B/zh not_active IP Right Cessation
- 2000-11-30 JP JP2000363933A patent/JP4000505B2/ja not_active Expired - Fee Related
- 2000-12-01 EP EP03013533A patent/EP1344535A3/en not_active Withdrawn
- 2000-12-01 CN CNA2004100787367A patent/CN1615879A/zh active Pending
- 2000-12-01 AT AT00978074T patent/ATE332145T1/de not_active IP Right Cessation
- 2000-12-01 DE DE60029242T patent/DE60029242T2/de not_active Expired - Fee Related
- 2000-12-01 KR KR10-2004-7004652A patent/KR20040045029A/ko not_active Application Discontinuation
- 2000-12-01 EP EP03013532A patent/EP1344534A3/en not_active Withdrawn
- 2000-12-01 CN CNB008166668A patent/CN1263512C/zh not_active Expired - Fee Related
- 2000-12-01 IL IL14944400A patent/IL149444A0/xx active IP Right Grant
- 2000-12-01 KR KR1020027006605A patent/KR100607430B1/ko not_active IP Right Cessation
- 2000-12-01 CA CA002392804A patent/CA2392804C/en not_active Expired - Fee Related
- 2000-12-01 RU RU2002114335/15A patent/RU2002114335A/ru unknown
- 2000-12-01 HU HU0204049A patent/HUP0204049A3/hu unknown
- 2000-12-01 ES ES00978074T patent/ES2267586T3/es not_active Expired - Lifetime
- 2000-12-01 CZ CZ20021829A patent/CZ20021829A3/cs unknown
- 2000-12-01 WO PCT/JP2000/008545 patent/WO2001039805A1/ja active IP Right Grant
- 2000-12-01 EP EP00978074A patent/EP1234582B1/en not_active Expired - Lifetime
- 2000-12-01 KR KR10-2004-7004651A patent/KR20040045028A/ko not_active Application Discontinuation
- 2000-12-01 CN CNA2004100787371A patent/CN1615880A/zh active Pending
- 2000-12-01 AU AU15575/01A patent/AU773110B2/en not_active Ceased
- 2000-12-01 NZ NZ518930A patent/NZ518930A/en unknown
- 2000-12-01 MX MXPA02005505A patent/MXPA02005505A/es active IP Right Grant
- 2000-12-01 PL PL355431A patent/PL201783B1/pl not_active IP Right Cessation
- 2000-12-01 BR BR0015980-8A patent/BR0015980A/pt not_active IP Right Cessation
-
2002
- 2002-05-02 IL IL149444A patent/IL149444A/en not_active IP Right Cessation
- 2002-05-16 US US10/146,747 patent/US7307096B2/en not_active Expired - Fee Related
- 2002-05-31 NO NO20022584A patent/NO20022584L/no not_active Application Discontinuation
- 2002-12-05 HK HK02108841.2A patent/HK1047239B/zh not_active IP Right Cessation
-
2004
- 2004-04-13 RU RU2004111357/15A patent/RU2299067C2/ru not_active IP Right Cessation
- 2004-04-13 RU RU2004111358/15A patent/RU2004111358A/ru not_active Application Discontinuation
- 2004-04-13 RU RU2004111359/15A patent/RU2004111359A/ru not_active Application Discontinuation
- 2004-08-10 US US10/916,052 patent/US20050043383A1/en not_active Abandoned
- 2004-08-10 US US10/915,855 patent/US20050014808A1/en not_active Abandoned
-
2007
- 2007-10-23 US US11/977,103 patent/US20080221184A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0015980A (pt) | Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii | |
NO971546D0 (no) | Reumatoid artritt-middel inneholdende IL-6-antagonist som aktiv bestanddel | |
DE60133029D1 (de) | Mittel zur prävention oder behandlung von psoriasi | |
NO20043013L (no) | Tetrahydrokinolin analoger som muskarine agonister | |
CY1107214T1 (el) | Αγωνιστες και ανταγωνιστες υποδοχεων λυσοφωσφατιδικου οξεος (lpa) kai τροποι χρησης | |
EP1108435A4 (en) | MEANS FOR PREVENTING OR TREATING PANCREATITIS CONTAINING THE IL-6 ANTAGONISTS AS ACTIVE COMPONENTS | |
DE69728585D1 (de) | Mittel gegen Juckreiz | |
PT1305286E (pt) | Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento | |
BR0211274A (pt) | Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase | |
MY129668A (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
WO2002028829A3 (en) | Peptide deformylase inhibitors | |
BR9809848A (pt) | Composição | |
EA200401137A1 (ru) | Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора | |
BR0116553A (pt) | Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão | |
BR0206917A (pt) | Uso de antagonistas de mglur5 para o tratamento de condições prurìticas | |
BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
BR0116762A (pt) | Análogos tacrolimus neurotróficos, métodos e uso dos mesmos | |
BR9907896A (pt) | "combinação de um antagÈnico alfa-adrenérgico e de um agente doador de óxido de nitrogênio para o tratamento de disfunções sexuais femininas" | |
ES2102370T3 (es) | Composicion antiparasitaria para uso animal. | |
DK1121108T3 (da) | Ny terapeutisk anvendelse af forbindelser med beta-3-agonistaktivitet | |
EP0992242A4 (en) | PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS | |
ES2188797T3 (es) | Sales de n-(4-oxo-2-(1h-tetrazoil-5-il)-4h-1 benzopran-8-il)-4-(4-fenilbutoxi)benzamida. | |
BG108033A (en) | Use of 2-amino-1-(4-hydroxy-2-methane sulphonamidophenyl)ethanol for treating urinary incontinence. | |
BR9902081A (pt) | Combinação de dofetilida e um bloqueador dos canais de cálcio | |
WO2002002089A3 (de) | Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011. |